Krechler T, Janda J, Dufek V, Kaláb M, Pesková M, Dorazilová V
1. interní klinika 1. LF UK a VFN, Praha.
Vnitr Lek. 1997 Oct;43(10):678-81.
The authors describe the procedure used for assessment of a Ki-ras mutation as a specific and sensitive marker of carcinoma of the pancreas. The reliability of the method was tested in five patients with carcinoma of the pancreas.
作者描述了将用于评估Ki-ras突变的程序作为胰腺癌的一种特异性和敏感性标志物。该方法的可靠性在5例胰腺癌患者中进行了测试。
